Profile
Chris Kemmerer worked as a Director of Pharmaceutical Development at Avera Pharmaceuticals, Inc. and as a Principal at Merck & Co., Inc. and Pfizer Inc. He also served as the VP of Pharmaceutical Development & Manufacturing at Neothetics, Inc. from 2009 to 2016.
Dr. Kemmerer holds a doctorate degree from Temple University and an undergraduate degree from The Pennsylvania State University.
Former positions of Chris Kemmerer
Companies | Position | End |
---|---|---|
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 2015-12-31 |
MERCK & CO., INC. | Corporate Officer/Principal | - |
PFIZER, INC. | Corporate Officer/Principal | - |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Training of Chris Kemmerer
The Pennsylvania State University | Undergraduate Degree |
Temple University (Pennsylvania) | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
Private companies | 2 |
---|---|
Neothetics, Inc.
Neothetics, Inc. Pharmaceuticals: MajorHealth Technology Neothetics, Inc. operates as a holding company, which provides clinical-stage specialty pharmaceutical and developing therapeutics for the aesthetic. It focuses on localized fat reduction and body contouring. The company products include LIPO-202, is an injectable formulation of the long-acting ß2-adrenergic receptor agonist, salmeterol xinafoate. Neothetics was founded by John D. Dobak in February 2007 and is headquartered in San Diego, CA. | Health Technology |
Avera Pharmaceuticals, Inc.
Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA. | Health Services |
- Stock Market
- Insiders
- Chris Kemmerer